We found that inhibition of two well studied oncogenic pathways (MEK1/2 and PLK1 axes) in breast cancer significantly reduced outgrowth of basal‐like syngeneic and human breast tumors xenografts in preclinical models. Here, MAP2K1 is linked to breast carcinoma.